Trial Profile
A Double-Blind,Randomized,Placebo-Controlled Trial of Mecamylamine Hydrochloride for the Treatment of SSRI-Refractory Major Depressive Disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Mecamylamine (Primary)
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- 12 Jan 2007 Status change
- 08 Nov 2006 New trial record.